Skip to main content

Acamprosate Calcium Tablets Shortage

Last Updated: April 14, 2025
Status: Current

Products Affected - Description
    • Acamprosate calcium oral tablet, Glenmark, 333 mg, bottle, 180 count, NDC 68462-0435-18
    • Acamprosate calcium oral tablet, Zydus, 333 mg, bottle, 180 count, NDC 68382-0569-28
Reason for the Shortage
    • Glenmark did not provide a reason for the shortage.
    • Viatris has acamprosate tablets available.
    • Zydus did not provide a reason for the shortage.
Available Products
    • Acamprosate calcium oral tablet, Mylan (Viatris), 333 mg, bottle, 180 count, NDC 00378-6333-80

Estimated Resupply Dates

    • Glenmark estimates the release of acamprosate 333 mg tablets of mid- to late-May 2025.
    • Zydus has temporarily discontinued acamprosate 333 mg tablets and the company cannot estimate a release date.

Updated

Updated April 14, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 30, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.